SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (18704)2/12/1999 12:09:00 PM
From: VLAD  Read Replies (2) of 23519
 
martin,

I believe we will see the best results on MUSE sales where Viagra was released first, had its big hype, and then the public starts getting informed about the heart attacks and deaths that occur and the Viagra hype dies off. You can bet that the MUSE safety profile is what Astra is going to use as its major selling point to the public and physicians. IMO about 6 months post Viagra launch is probably the most opportune time for Astra to be introducing a much safer local alternative to Viagra.

Our big problem in the US market with MUSE is EDUCATION of the PCPs and the public. Again it all boils down to one thing which is Leland stepping down as the CEO of this company and allowing a competent leader to get a domestic partner signed. He couldn't do it 1, 2, 3, 4, 5, 6, or even 7 months ago. Why should we believe he will be able to do it if we give him another month or two?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext